Calaspargase Pegol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14730 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 45 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | insomnia (disease) | KG + DL |
| 2 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 3 | heparin cofactor 2 deficiency | KG + DL |
| 4 | antithrombin deficiency type 2 | KG + DL |
| 5 | thrombophilia | KG + DL |
| 6 | endocardial fibroelastosis | KG + DL |
| 7 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 8 | endocarditis | KG + DL |
| 9 | benign recurrent intrahepatic cholestasis | KG + DL |
| 10 | thrombotic disease | KG + DL |
| 11 | severe nonproliferative diabetic retinopathy | KG + DL |
| 12 | idiopathic granulomatous myositis | KG + DL |
| 13 | myositis fibrosa | KG + DL |
| 14 | cholestasis | KG + DL |
| 15 | diabetic retinopathy | KG + DL |
| 16 | tendinitis | KG + DL |
| 17 | familial intrahepatic cholestasis | KG + DL |
| 18 | inborn disorder of bilirubin metabolism | KG + DL |
| 19 | non-syndromic visceral malformation | KG + DL |
| 20 | diabetic cataract | KG + DL |
| 21 | biliary atresia intrahepatic | KG + DL |
| 22 | bilirubin metabolism disease | KG + DL |
| 23 | Mirizzi syndrome | KG + DL |
| 24 | inclusion body myositis | KG + DL |
| 25 | microvillus inclusion disease | KG + DL |
| 26 | craniostenosis cataract | KG + DL |
| 27 | diabetes mellitus type 2 associated cataract | KG + DL |
| 28 | mature cataract | KG + DL |
| 29 | immature cataract | KG + DL |
| 30 | tetanic cataract | KG + DL |
| 31 | nuclear senile cataract | KG + DL |
| 32 | cortical cataract | KG + DL |
| 33 | nevus of Ito | KG + DL |
| 34 | senile cataract | KG + DL |
| 35 | hereditary North American Indian childhood cirrhosis | KG + DL |
| 36 | substance abuse/dependence | KG + DL |
| 37 | drug-induced liver injury | KG + DL |
| 38 | hyperbiliverdinemia | KG + DL |
| 39 | mitochondrial DNA depletion syndrome, hepatocerebral form | KG + DL |
| 40 | Navajo neurohepatopathy | KG + DL |
| 41 | cavernous sinus thrombosis | KG + DL |
| 42 | lateral sinus thrombosis | KG + DL |
| 43 | adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency | KG + DL |
| 44 | chromosome 17q12 deletion syndrome | KG + DL |
| 45 | fibromyalgia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.